Michael L. Meyers SEC EDGAR Filings (CIK 0001664204)

SEC EDGAR filings, ownership reports, and insider transactions for Michael L. Meyers.

Business address
C/O Syndax Pharmaceuticals, Inc., 400 Totten Pond Road, Suite 110, Waltham, MA, 02451
Top holdings (ownership)
SNDX and NUVL
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Michael L. Meyers has filed 18 SEC EDGAR filings since 02 Mar 2016

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 20 Jun 2025 18 Jun 2025 001-40671
4 Open Document Open Filing 4 14 Jun 2024 12 Jun 2024 001-40671
4 Open Document Open Filing FORM 4 SUBMISSION 16 Jun 2023 15 Jun 2023 001-40671
4 Open Document Open Filing FORM 4 SUBMISSION 06 Oct 2022 04 Oct 2022 001-40671
3 Open Document Open Filing FORM 3 SUBMISSION 06 Oct 2022 04 Oct 2022 001-40671
4 Open Document Open Filing PRIMARY DOCUMENT 03 Feb 2022 02 Feb 2022 001-37708
4 Open Document Open Filing PRIMARY DOCUMENT 03 Jan 2022 30 Dec 2021 001-37708
4 Open Document Open Filing PRIMARY DOCUMENT 28 Apr 2021 26 Apr 2021 001-37708
4 Open Document Open Filing PRIMARY DOCUMENT 05 Feb 2021 03 Feb 2021 001-37708
4 Open Document Open Filing PRIMARY DOCUMENT 08 Jul 2020 06 Jul 2020 001-37708
4 Open Document Open Filing PRIMARY DOCUMENT 14 Feb 2020 12 Feb 2020 001-37708
4/A Open Document Open Filing PRIMARY DOCUMENT 25 Mar 2019 21 Mar 2019 001-37708
4 Open Document Open Filing PRIMARY DOCUMENT 22 Mar 2019 21 Mar 2019 001-37708
4 Open Document Open Filing PRIMARY DOCUMENT 08 Feb 2019 06 Feb 2019 001-37708
4 Open Document Open Filing PRIMARY DOCUMENT 07 Nov 2018 30 Oct 2018 001-37708
4 Open Document Open Filing PRIMARY DOCUMENT 05 Mar 2018 01 Mar 2018 001-37708
4 Open Document Open Filing PRIMARY DOCUMENT 08 Feb 2017 06 Feb 2017 001-37708
3 Open Document Open Filing PRIMARY DOCUMENT 02 Mar 2016 02 Mar 2016 001-37708